You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Cost considerations of the new fixed combination for glaucoma medical therapy
- In: SIG Pharmacoeconomics/Pharmacoepidemiology - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: PP-P-024
- By: CHEN, Hsien-Li (Chang Gung Memorial Hospital, Taipei, China Taiwan)
- Co-author(s): Deng, Shin-Tarng (Chang Gung Memorial Hospital, TAOYUN, China Taiwan)
Hsieh, Ming-Chieh (Chang Gung Memorial Hospital, TAOYUN, China Taiwan)
Mau, Jan-Yen* (Chang Gung Memorial Hospital, TAIPEI, China Taiwan) - Abstract:
Aims: To determine the daily cost of the CosoptÂ[RSYMBOL] (Dorzolamide/Timolol), CombiganÂ[RSYMBOL] (brimonidine tartrate/timolol), and XalacomÂ[RSYMBOL] (latanoprost /timolol) for medical therapy of glaucoma.
Methods: The studied drugs were: CosoptÂ[RSYMBOL] (5.0 ml/ bottle) and CombiganÂ[RSYMBOL] (5.0 ml/ bottle), and XalacomÂ[RSYMBOL].. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026